Physitrack PLC (Nasdaq First North Growth Market Stockholm: PTRK) (the “Company”) announces that, in accordance with the share buy-back programme announced on 21 July 2026, it has undertaken the following transactions under the programme during the period 17–21 August 2026 (the “week”). The buy-back is carried out by Pareto Securities AB on behalf of the Company.
Summary of transactions
| Period | 17–21 August 2026 |
| Total shares repurchased during the week | 7,250 |
| Volume-weighted average price paid (SEK) | 8.4483 |
| Total consideration paid (SEK) | SEK 61,250 |
| Total shares held by the Company (treasury) following these transactions | 14,500 |
| Total outstanding shares in the Company | 16,260,766 |
| Treasury holding as % of issued share capital* | 0.089% |
*Treasury holding as a percentage of issued share capital is calculated on the basis: shares held by the Company ÷ (total outstanding shares + shares held by the Company), using the most recent figures reported by Pareto Securities. Figures are rounded to the nearest SEK 0.01 / whole share where applicable.
Individual transactions
| Date | Quantity | Average price (SEK) |
| 2026-08-17 | 1,500 | 8.6667 |
| 2026-08-18 | 1,500 | 8.5933 |
| 2026-08-19 | 1,750 | 8.3257 |
| 2026-08-20 | 1,000 | 8.30 |
| 2026-08-21 | 1,500 | 8.3267 |
The buy-back programme is conducted within the safe harbour provided by Article 5 of the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and Commission Delegated Regulation (EU) 2016/1052, for the purpose of meeting the Company's obligations under its employee share plans. The programme is executed by Pareto Securities AB on a non-discretionary basis on Nasdaq First North Growth Market Stockholm.
Notification details
| 1. Issuer | Physitrack PLC, LEI 213800PC4QYNWHPCP774 |
| 2. Instrument / ISIN | Ordinary shares / GB00BYX22590 |
| 3. Trading venue | Nasdaq First North Growth Market Stockholm (PTRK) |
| 4. Currency | SEK |
| 5. Purpose of buy-back | To meet the Company's obligations under its employee share plans (a permitted purpose under Article 5(2) of MAR) |
| 6. Executing broker | Pareto Securities AB (non-discretionary mandate) |
This information is disclosed by Physitrack PLC pursuant to Article 5 of the Market Abuse Regulation (EU) No 596/2014, as implemented by Commission Delegated Regulation (EU) 2016/1052.